Lice Infestations Clinical Trial
Official title:
Phase II, Multi-center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis
In a previous phase II study, the safety and efficacy of a novel formulation of malathion
0.5% was evaluated in patients 2 years of age and older. Based on the results of that study,
this formulation is currently in a phase III study for that population.
The current study will use blood markers and clinical evaluations to determine the safety
and tolerability of this formulation when used in children 6-24 months of age.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00819520 -
Ivermectin in the Treatment of Head Lice
|
Phase 3 | |
| Completed |
NCT00244439 -
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
|
Phase 3 | |
| Recruiting |
NCT05565820 -
A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation
|
Phase 4 |